Ligand validation:3PLA

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 3PLA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PLA_SAH_F_301	27%	37%	0.252	0.898	1.08	1.39	2	5	0	0	100%	1
3PLA_SAH_E_301	24%	34%	0.248	0.876	1.08	1.52	2	4	0	0	100%	1
3PLA_SAH_M_301	3%	37%	0.398	0.734	1.06	1.4	2	4	0	0	100%	1
7XPL_SAH_E_301	57%	27%	0.161	0.937	1.25	1.67	2	4	0	0	100%	1
5GIP_SAH_E_301	57%	30%	0.178	0.953	1.25	1.54	2	5	2	0	100%	1
5GIN_SAH_E_301	34%	22%	0.228	0.915	1.35	1.85	3	3	0	0	100%	1
5GIO_SAH_F_301	13%	30%	0.313	0.857	1.2	1.59	3	5	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
6U8W_SAH_A_901	100%	22%	0.028	0.995	1.23	1.96	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.